Effect of baduanjin on cognitive function and quality of life in breast cancer patients undergoing chemotherapy: a randomized controlled trial.
Phase 1
Not yet recruiting
- Conditions
- Breast cancer
- Registration Number
- ITMCTR2000003324
- Lead Sponsor
- The Seventh People's Hospital affiliated to Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
(1) female patients newly diagnosed stage I to III breast cancer;
(2) schedule to receive adjuvant chemotherapy;
(3) aged 40 to 75 years;
(4) sufficient fluency of the Chinese language; and
(5) willing to participate in the study and be randomly assigned
Exclusion Criteria
(1) disease recurrence or metastasis;
(2) known conditions and/or diseases that impact cognition (eg, Alzheimers disease, dementia, or other psychological diagnoses);
(3) disorders that might preclude exercise participation (eg, fracture, arthritis); and
(4) current/planned participation in mindfulness-based exercise programs (eg, TaiChi or Qigong).
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method